Pre-Clinical evaluation of the Pharmacodynamic Properties of RH1 (2,5-diaziridinyl-3-(hydroxymethyl)-6-methyl-1,4-benzoquinone)

TH Ward, S Danson, N Coe, AT McGown, M Ranson, L Disley, GC Jayson, J Butler

Research output: Contribution to journal › Article › peer-review

Cite this

@article{43601580315d474486c5c4ebc53ff71c,

title = "Pre-Clinical evaluation of the Pharmacodynamic Properties of RH1 (2,5-diaziridinyl-3-(hydroxymethyl)-6-methyl-1,4-benzoquinone)",

author = "TH Ward and S Danson and N Coe and AT McGown and M Ranson and L Disley and GC Jayson and J Butler",

year = "2005",

language = "English",

pages = "2695--2701",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research",

}

TY - JOUR

T1 - Pre-Clinical evaluation of the Pharmacodynamic Properties of RH1 (2,5-diaziridinyl-3-(hydroxymethyl)-6-methyl-1,4-benzoquinone)

AU - Ward, TH

AU - Danson, S

AU - Coe, N

AU - McGown, AT

AU - Ranson, M

AU - Disley, L

AU - Jayson, GC

AU - Butler, J

PY - 2005

Y1 - 2005

M3 - Article

SN - 1078-0432

SP - 2695

EP - 2701

JO - Clinical Cancer Research

JF - Clinical Cancer Research

ER -